Recent years have seen major advances in our understanding of the neurochemical basis of dementia of the Alzheimer type. Its distinctive neuropathological features include plaques, neurofibrillary tangles, and other changes, but three reports in 1976-81-3 also described appreciable reductions in the activity of the enzyme choline acetyltransferase (which synthesises acetylcholine) in cerebral cortex from patients who had died of dementia of the Alzheimer type. These studies generated considerable interest in the cholinergic system in dementia: the currently influential theory that cholinergic dysfunction underlies the clinical features has recently been well reviewed by Coyle, Prince, and DeLong. 4 Reductions in cortical choline acetyltransferase activity in postmortem or biopsy samples of brain occur in specific association with the classical neuropathological changes of Alzheimer's disease: they are not found consistently, for example, in multi-infarct dementia. Furthermore, the severity of the neuropathological changes is associated with the extent of the reductions in choline acetyltransferase and cognitive impairment.5 6 Alzheimer type neuropathological changes are most pronounced in the temporal cortex and hippocampus and so are the reductions in choline acetyltransferase activity; these changes may be responsible for the defects in new learning. Neocortical neuropathological lesions and reductions in choline acetyltransferase are more pronounced in patients with a younger age of onset,7 and these changes might underlie apraxias, aphasias, and agnosias.
Neuroanatomical studies suggest that the cortex does not contain intrinsic cholinergic cell bodies, but that it receives an extrinsic innervation of cholinergic nerve terminals originating from subcortical neurones of the substantia innominata, nucleus of the diagonal band of Broca, and septal nuclei. First in any discussion of AIDS must be its definition. At present any of the many illnesses common in people known to be immunosuppressed might be classified as related to AIDS by one or another investigator. Apparently no common definition is being used in Europe, and this alone may account for the considerable differences in case counts observed among different nations. Epidemiologically this has conflicting results: the wider the net is cast, the more the case yield-but equally the more extraneous and confusing material is included. Since the disease spectrum seen in Europe resembles that in the United States we recommend that the definition used by the Centers for Disease Control in the United States should be used to make data concordant on the two sides of the Atlantic.
